1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Sweden >
  5. Orexo Acquires Biolipox AB

M&A Deal Summary

Orexo Acquires Biolipox AB

On October 15, 2007, Orexo acquired life science company Biolipox AB

Acquisition Highlights
  • This is Orexo’s 1st transaction in the Life Science sector.
  • This is Orexo’s 1st transaction in Sweden.

M&A Deal Summary
Date 2007-10-15
Target Biolipox AB
Sector Life Science
Buyer(s) Orexo
Deal Type Add-on Acquisition

Target

Biolipox AB

Solna, Sweden
Biolipox AB is a drug company focused on therapies for inflammatory diseases, including pain management and respiratory diseases like asthma and chronic obstructive pulmonary disease.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Orexo

Uppsala, Sweden
Category Company
Founded 1994
Sector Healthcare Services
Employees110
Revenue 590M SEK (2024)
DESCRIPTION

Orexo focusing on developing treatments for pain and inflammation. Orexo was founded in 1994 and is based in Uppsala, Sweden.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Sweden M&A 1 of 1
Year: 2007 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal